1ST Year
Investment
a. Total Cost at Completion Rs. 591 Million
Total Production of ASV from 50 Horses in 5 Cycles 60000 vials of 10 ml or if lyophilized
Market appreciable value/ vial Rs. 1000/ Vial
(Presently polyvalent lyophilized serum from India costs Rs. 1500-2000/ vial and NIH made Liquid ASV at rate of Rs. 700/ Vial, although both are having old Ammonium Sulphate precipitation method whereas Sindh Project is having modern techniques)
Possible Income if entire stock sold out Rs.60,000,000 (60 m)
Investment Rs 591 Million
Income Rs. 60 Million
Net Outstanding Rs. – 531 Million
2nd Year
Investment
a. Balance Capital Cost Rs. -531 Million
- Annual Recurring expenses Rs. 18.00 Million
- Total Rs. 549.00 Million
Total Production of ASV from 100 Horses in 5 Cycles 60000 vials of 10 ml or if lyophilized
Market appreciable value of Lyophilized ASV Rs. 1000/ Vial
Possible Income if entire stock sold out Rs. 60,000,000
Outstanding Rs. 549 Million
Income Rs. 60 Million
Net Rs. 489 Million
With the increasing demand the lab can generate more profits without further investment except expenditure for purchase of additional animals, construction cost of their housing and additional feeding and additional chemical costs. It is therefore likely that the project itself will return the initial investment within 15 to 20 years of operation if no retreating factor involves, however it will carry potential of expansion for production of other essential sera like Anti rabies vaccine (ARV) with minor investments to multifold the profit ratio and recovery of initial investment much earlier.